Sotera Health Acquires Life Sciences Consulting Company

Article

Sotera’s acquisition of Regulatory Compliance Associates (RCA) will expand its technical consulting services.

Sotera Health, a global provider of sterilization, lab-testing, and advisory services, announced on Nov. 9., 2021, that it had acquired Regulatory Compliance Associates (RCA), a Wisconsin-based life sciences consulting company. Terms of the deal were not disclosed.

Founded in 2000, RCA specializes in quality, regulatory, and technical consulting for the pharmaceutical, medical device, and combination device industries. According to a company press release, this acquisition will allow RCA’s consulting capabilities to complement and enhance Sotera Health’s existing strengths in technical consulting and expert advisory services.

“Regulatory Compliance Associates is a premier provider of quality and regulatory services; known for its best-in-class solutions. It is also recognized for its strong relationships with its customers and regulators,” said Michael B. Petras Jr., chairman and CEO of Sotera Health, in the press release. “This acquisition will expand and further strengthen our technical consulting capabilities. We welcome RCA’s strong management and expert staff as they join us in our mission, Safeguarding Global Health.”

“Our mission is to provide our customers with unsurpassed technical expertise combined with quality service. We have earned a reputation for our customer service and are seen as an essential partner for our customers—and we know we have found the same in Sotera Health,” said Erika Porcelli, CEO of RCA, in the press release. “My goal for RCA is to continue our commitment to serve customers supporting their regulatory and compliance needs as they bring critical pharma and medical device products to market. We accomplish this by becoming part of Sotera Health, a global company whose breadth of services and expansive reach provide extraordinary value to the industries we are proud to serve.”

Source: Regulatory Compliance Associates

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content